Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Drug Manufacturers Face Public Opinion Challenge In Medicare Rx

Executive Summary

Pharmaceutical manufacturers face a significant challenge in countering bad publicity about the Medicare prescription drug program, National Pharmaceutical Council President Karen Williams said at a World Congress Leadership Summit on Medicare May 23 in Washington, D.C

You may also be interested in...

Medicare Population Shows Little Pharmacy Loyalty, Medco Says

Medicare beneficiaries in the discount card program are demonstrating little loyalty to particular pharmacies, Medco Senior VP-Medical Affairs Robert Epstein said

Medicare Rx Plans Likely To Focus On Managing Use Of Low-Cost Drugs

The catastrophic coverage provided under the Medicare Part D benefit may give private plan sponsors little incentive to control use of high-cost drugs, American Enterprise Institute Resident Fellow Scott Gottlieb said April 27

Medicare Rx Requires Pharmacies To Mind Their B’s And D’s

Pharmacists will have to keep careful track of prescriptions for some medicines that can be covered by Medicare Part B once the new Part D outpatient drug benefit begins in 2006

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts